Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004424956 | SCV004908778 | uncertain significance | not specified | 2023-10-10 | criteria provided, single submitter | clinical testing | The c.1102G>C (p.E368Q) alteration is located in exon 7 (coding exon 6) of the ARHGEF16 gene. This alteration results from a G to C substitution at nucleotide position 1102, causing the glutamic acid (E) at amino acid position 368 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |